News

Main Office
410.417.3685
Email Public Affairs
Site Map

Quick Links
Contracting
Careers
Press Kit
Accessibility Statement
DOD Site Statement
Privacy Policy
Security Policy
No FEAR Act

Resources
CBRN Resource Library
JACKS
Legal Administrative
FOIA
Office of the IG
Contact USA.gov

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

DOD Supports Phase II Clinical Trials Repurposing Inhaled PUL-042 for COVID-19 Prevention and Treatment
January 26, 2021 — The JPM CBRN Medical executed an agreement with Pulmotect, Inc. to study the effectiveness of an existing compound that shows promise against COVID-19... MORE

Increased Collaboration Promotes Improved Medical Diagnostic Capabilities and Health Outcomes
January 25, 2021 — The U.S. Department of Defense (DOD) has a long-standing history of developing medical countermeasures (MCMs) to combat deadly biological threats. Vaccines, diagnostics, and therapeutics serve in a fully-layered continuum of defense capabilities that both protect before exposure as well as to inform and treat after exposure. This set of... MORE

HHS, DOD purchase additional doses of Regeneron therapeutic to treat patients with mild to moderate COVID-19
January 12, 2021 — The Department of Health and Human Services (HHS) and the Department of Defense (DOD) today announced the purchase of 1.25 million additional treatment courses of Regeneron’s investigational monoclonal antibody therapeutic, a combination of casirivimab and imdevimab, to be delivered in the first half of 2021 to treat non-hospitalized, high-risk... MORE

DOD Awards University of Louisville $8.5 Million for COVID-19 Q-Griffithsin Repurposing Effort
December 9, 2020 — The JPM CBRN Medical leveraged an academic partnership to study the repurposing of a compound that shows promise against COVID-19... MORE

JPM CBRN Medical Tiger Team Takes Bold Action to Support Pandemic Response
December 4, 2020 — It is difficult to remember a time when “coronavirus” was not a part of our day-to-day vocabulary. The COVID-19 pandemic emerged from the shadows and threw the world into a tailspin, demanding ingenuity and resourcefulness as it pushed worldwide healthcare systems to their limits. As nations quickly scrambled to adapt and respond to the global... MORE

News Archive - Search by Year and Month

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.

The information contained in these articles has been reviewed and approved for public release.

The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.